Allarity Therapeutics与美国退伍军人事务部合作开展Stenoparib联合替莫唑胺治疗复发性小细胞肺癌的II期临床试验现开放入组

美股速递
Feb 03

Allarity Therapeutics宣布,其与美国退伍军人事务部合作开展的II期临床试验现已开放患者入组。该试验旨在评估Stenoparib与替莫唑胺联合疗法治疗复发性小细胞肺癌的疗效与安全性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10